| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | CA2513107A1 Protein microarray system |
| 07/28/2004 | CN1515590A Erythropoietin conjugate |
| 07/28/2004 | CN1159581C Protein chip for immunological analysis |
| 07/27/2004 | US6767993 Methods and compositions for peptide synthesis |
| 07/27/2004 | US6767635 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 07/22/2004 | WO2004060304A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060041A2 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | WO2004007661A3 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 07/22/2004 | CA2512138A1 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | CA2511817A1 Novel compositions and methods in cancer |
| 07/20/2004 | CA2107683C Immobilization of chemical species in crosslinked matrices |
| 07/15/2004 | WO2004058953A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 07/15/2004 | WO2004058946A2 Protein arrays |
| 07/15/2004 | WO2004058188A2 Vaccine compositions and methods |
| 07/15/2004 | US20040137543 Bacteriotoxin adsorbents and method of screening the same |
| 07/15/2004 | US20040137527 Method for producing a layer of functional molecules |
| 07/15/2004 | CA2511243A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 07/15/2004 | CA2510173A1 Vaccine compositions and methods |
| 07/15/2004 | CA2508939A1 Protein arrays |
| 07/14/2004 | EP1437368A1 Composition for polymerising immobilisation of biological molecules and method for producing said composition |
| 07/14/2004 | EP1363935A4 Ter sites and ter binding proteins |
| 07/14/2004 | EP1313440A4 Dental products comprising bone growth enhancing peptide |
| 07/14/2004 | CN1157411C Recombination method of substrate mediated membrane protein in lipid bilayer |
| 07/08/2004 | WO2004056970A2 Chemo-enzymatic process for proteome-wide mapping of post-translational modification |
| 07/08/2004 | WO2004056309A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 07/08/2004 | US20040132149 for the concentration, separation and/or fixation of other amino acids, peptides, proteins or more complex molecules with peptidic structural units |
| 07/08/2004 | US20040132005 Method of forming biochip and application thereof |
| 07/08/2004 | CA2508276A1 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 07/07/2004 | EP1435360A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 07/07/2004 | EP1412517A4 Methods, kits and compositions of combination oligomers |
| 07/07/2004 | CN1156702C Protein chip based on labeling streptavid-biotin technology |
| 07/01/2004 | US20040126900 Water-soluble polymeric nanoparticle functionalized by at least two peptide moieties with high affinity to therapeutic and cell surface proteins |
| 07/01/2004 | US20040126839 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432443A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 06/30/2004 | EP1303559A4 Activated modular grafted polymeric surfaces |
| 06/30/2004 | CN1155618C PEG-interferon conjugates |
| 06/29/2004 | US6756217 Glass composite materials containing alkoxosilane derivative having alterable charge, hydrophobic and hydrophilic groups |
| 06/29/2004 | US6756041 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/24/2004 | WO2004052273A2 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 06/24/2004 | US20040121400 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine |
| 06/24/2004 | US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/24/2004 | US20040120946 capable of efficient and selective adsorption of an antibody against beta 1-adrenoceptor and/or an antibody against M2 muscarinic receptor occurring in a body fluid (e.g. blood, plasma or the like) without requiring a pretreatment |
| 06/24/2004 | CA2507980A1 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 06/23/2004 | EP1431312A1 Method for production and a composition for immobilising biological macromolecules in hydrogels and the use of said composition for producing biochips |
| 06/23/2004 | EP1429798A1 Optimal compositions and methods thereof for treating hcv infections |
| 06/23/2004 | CN1154727C Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner |
| 06/17/2004 | US20040116649 Polyoxyethylene glycol; purity, storage stability |
| 06/17/2004 | US20040115216 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 06/17/2004 | US20040114780 Pixel arrays |
| 06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | WO2004047746A2 Regulation of stearoyl-coa desaturase to treat obesity |
| 06/10/2004 | US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 06/10/2004 | US20040110735 Methods of activating receptor using amphiphilic drug-oligomer conjugates |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2476691A1 Novel proteins and nucleic acids encoding same |
| 06/09/2004 | EP1425306A2 Nanoparticles comprising biologically active tnf which is immobilised on the same |
| 06/09/2004 | EP1101115B1 Method for preparing water-soluble cross-linked conjugates |
| 06/08/2004 | US6747143 Methods for polymer synthesis |
| 06/03/2004 | WO2004046365A2 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | US20040106772 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 06/03/2004 | US20040106127 Comprises nucleotide sequences coding human adult and embryonic whole brain polypeptides; microarry for genome analysis; proteomics |
| 06/03/2004 | CA2504267A1 Interferon-alpha polypeptides and conjugates |
| 06/02/2004 | EP1423135A2 Methods for inhibiting angiogenesis |
| 06/02/2004 | EP0948344A4 Synthetic antibiotics |
| 06/02/2004 | CN1501815A New interferon beta-like molecules |
| 05/27/2004 | WO2004044573A1 Transistor-based biosensors having gate electrodes coated with receptor molecules |
| 05/27/2004 | WO2004044006A1 Conjugates of interleukin-10 and polymers |
| 05/27/2004 | WO2004043386A2 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | WO2004043141A2 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians |
| 05/27/2004 | US20040102381 Methods of altering the binding affinity of a peptide to its receptor |
| 05/27/2004 | CA2813515A1 T cell receptor display |
| 05/27/2004 | CA2505546A1 Molecules preferentially associated with effector t cells and methods of their use |
| 05/26/2004 | EP1421104A2 Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| 05/25/2004 | US6740506 End selection in directed evolution |
| 05/21/2004 | WO2004042060A1 Method of immobilising a protein to a zeolite |
| 05/21/2004 | CA2545304A1 Method of immobilising a protein to a zeolite |
| 05/19/2004 | EP0862624B1 Water soluble cross-linking agents |
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/18/2004 | US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 05/18/2004 | CA2061519C Packings combining protein to a support via a spacer |
| 05/13/2004 | US20040092434 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 05/13/2004 | US20040092017 Binary viral expression system in plants |
| 05/13/2004 | US20040091959 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; diagnosis cancer |
| 05/13/2004 | US20040091488 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/12/2004 | EP1417236A2 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 05/12/2004 | EP1417235A1 Method for immobilization of polypeptides |
| 05/06/2004 | WO2004038402A1 Improved deposition of dissolved analyte to hydrophobic surfaces by desolvation of organic solvents |
| 05/06/2004 | WO2004037847A2 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | WO2002092788A9 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 05/06/2004 | US20040086544 Polymers with bioactive agents |
| 05/06/2004 | EP1415006A2 Assay for identifying inhibitors of hiv rt dimerization |
| 05/06/2004 | CA2482744A1 Hiv envelope-cd4 complexes and hybrids |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 04/29/2004 | WO2004036011A2 Biomolecular-based actuator |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2002066056A8 Synthetic vaccines comprising polyhydroxypolymer carriers |